Clicky

Anixa Biosciences, Inc.(ANIX) News

Date Title
Nov 8 Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Sep 30 Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial
Aug 26 Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Jul 29 Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting
Jul 26 We're Hopeful That Anixa Biosciences (NASDAQ:ANIX) Will Use Its Cash Wisely
Jul 23 Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy
Jul 23 EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy
Jun 24 Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial
May 9 Anixa expands cancer vaccine collaboration with Cleveland Clinic
May 8 Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines
May 7 Sidoti Events, LLC's Virtual May Micro-Cap Conference
May 6 Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja
Apr 30 Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024
Apr 18 Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
Mar 14 Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Mar 11 Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
Jan 23 Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology
Jan 16 Sidoti Events, LLC's Virtual January Micro-Cap Conference
Jan 10 Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024
Dec 14 Anixa Biosciences to Present at Biotech Showcase 2024